The RJX Solution - A case study of Phil Jones (Short) from rjx Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: This case study covers the treatment and results for Mr Phil Jones from Sydney, Australia, following the Reven Pharmaceuticals, Rejuveinix (RJX) treatment.nPhil is a 67-year-old suffering from Critical Limb Ischemia (CLI) loss of feeling in the lower limbs as a result of type 2 Diabetes. Phil’s treatments have been conducted under a Category A special access scheme, authorised by the Australian Therapeutic Administration (TGA). TGA is the Australian equivalent of the American Food & Drug a
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)